# EDGAR Filing Document

**Accession Number:** 0001825349
**File Stem:** 0001213900-25-052299
**Filing Date:** 2025-6
**Character Count:** 5367
**Document Hash:** fd29c9a22f06f7e24ba7e6d2a3603c51
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-052299.hdr.sgml**: 20250822

**ACCESSION NUMBER**: 0001213900-25-052299

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20250609

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Chanson International Holding
- **CENTRAL INDEX KEY:** 0001825349
- **STANDARD INDUSTRIAL CLASSIFICATION:** FOOD & KINDRED PRODUCTS [2000]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** B9 XINJIANG CHUANGBO ZHIGU INDUSTRIAL PK
- **STREET 2:** NO.100 GUANGYUAN ROAD SHUIMOGOU DISTRICT
- **CITY:** URUMQI, XINJIANG
- **STATE:** F4
- **ZIP:** 830017
- **BUSINESS PHONE:** 86-0991-2302709

**MAIL ADDRESS:**
- **STREET 1:** B9 XINJIANG CHUANGBO ZHIGU INDUSTRIAL PK
- **STREET 2:** NO.100 GUANGYUAN ROAD SHUIMOGOU DISTRICT
- **CITY:** URUMQI, XINJIANG
- **STATE:** F4
- **ZIP:** 830017

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** RON Holding Ltd
- **DATE OF NAME CHANGE:** 20200918

---

| | | |
|:---|:---|:---|
| ![](image_001.jpg) | <br> **Loeb & Loeb LLP**<br> 2206-19 Jardine House<br> 1 Connaught Place, Central<br> Hong Kong<br> Tel +852 3923 1111<br> Fax +852 3923 1100<br> Email HongKong@loeb.com | **樂博律師事務所有限法律責任合夥**<br> 香港中環康樂廣場1號<br> 怡和大廈2206-19室<br> 電話 +852 3923 1111<br> 傳真 +852 3923 1100<br> 電郵 HongKong@loeb.com |

---

Via EDGAR

June 9, 2025

Kristin Baldwin and Asia Timmons-Pierce

Office of Manufacturing

Division of Corporation Finance

U.S. Securities & Exchange Commission

100 F Street, NE

Washington, D.C. 20549

Re: Chanson International Holding

Amendment No. 1 to Registration Statement on Form F-1

Filed May 30, 2025

File No. 333-287404

Dear Ms. Baldwin and Ms. Timmons-Pierce:

On behalf of our client, Chanson International Holding (the "**Company**"), we hereby provide a response to the comments issued in a letter dated June 6, 2025 (the "**Staff's Letter**") regarding the Company's Amendment No. 2. To Registration Statement on Form F-1 (the "**Registration Statement**"). Contemporaneously, we are filing an Amendment No. 2 to the Registration Statement via EDGAR (the "**Amendment No. 2**").

In order to facilitate the review by the staff of the Securities and Exchange Commission (the "**Staff**") of the Amendment No. 2, we have responded, on behalf of the Company, to the comments set forth in the Staff's Letter on a point-by-point basis. The numbered paragraphs set forth below respond to the Staff's comments and correspond to the numbered paragraph in the Staff's Letter.

**<u>Form F-1/A filed May 30, 2025</u>**

**<u>Cover Page</u>**

**1.** **We note that you are registering 25,000,000 units (the "Units"), consisting of one Class A Ordinary Share, or, in lieu thereof, a pre-funded warrant; one series A warrant to purchase one Class A Ordinary Share; and one series B warrant to purchase one Class A Ordinary Share. Please revise the cover page header and your disclosure on page 16 to reflect the Units.** 

**Response:** The Company respectfully advises the Staff that the cover page and disclosure on page 16 had been updated to reflect the Units.

---

| | |
|:---|:---|
| ![](image_002.jpg) | Page 2 |

---

**2.** **Please revise your reference from "zero price exercise" to "zero exercise price" throughout the prospectus.** 

**Response:** The Company respectfully advises the Staff that reference of "zero price exercise" had been revised and replaced by "zero exercise price" or "zero exercise price option" throughout the prospectus.

**3.** **We note your response to prior comment 1. Please ensure your fee table reflects the number of securities being registered.** 

**Response:** The Company respectfully advises the Staff that the fee table had been updated and filed to include the following statement:

"**<u>However, a holder of the Series B Warrants may also effect the zero exercise price option at any time while the Series B Warrants are outstanding. Under the zero exercise price option, the holder of the Series B Warrants, has the right to receive the number of Class A Ordinary Shares as set forth in the applicable Series B Warrant, which will be more than such number of Class A Ordinary Shares that is issuable upon cash exercise or cashless exercise. We do not expect to receive any proceeds from the zero exercise price option of the Series B Warrants because it is highly unlikely that a holder of the Series B Warrants would elect to exercise the Series B Warrants by paying cash or via cashless exercise in lieu of the zero exercise price option. The maximum number of Class A Ordinary Shares issuable under all Series B Warrants (including the zero exercise price option) shall not exceed 75,000,000. As such, holders of the Series B Warrants may elect to be issued up to 75,000,000 Class A Ordinary Shares upon the zero exercise price option.</u>**" (added text in bold and underlined)

Please contact me at +852-3923 1187, Joan S. Guilfoyle at +1 (202) 524 8467 or Benjamin Yao at +852-3923 1154 if you would like additional information with respect to any of the foregoing. Thank you.

---

| |
|:---|
| Sincerely, |
| /s/ Henry Yin |
| Henry Yin |

---

cc: Gang Li, Chief Executive Officer, Chanson International Holding